Healthcare provider profile · identity verified

Kit C Helm, MD

Family Practice · FRANKLIN, NC · NPI 1336173749

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	391	98
Lisinopril	Lisinopril	369	91
Atorvastatin Calcium	Atorvastatin Calcium	349	94
Amlodipine Besylate	Amlodipine Besylate	325	83
Rosuvastatin Calcium	Rosuvastatin Calcium	284	68
Tamsulosin Hcl	Tamsulosin Hcl	258	64
Metoprolol Succinate	Metoprolol Succinate	234	64
Eliquis	Apixaban	228	41
Pantoprazole Sodium	Pantoprazole Sodium	223	65
Tramadol Hcl	Tramadol Hcl	219	45
Losartan Potassium	Losartan Potassium	218	63
Gabapentin	Gabapentin	198	59
Potassium Chloride	Potassium Chloride	198	54
Sertraline Hcl	Sertraline Hcl	193	41
Simvastatin	Simvastatin	179	49
Metformin Hcl	Metformin Hcl	174	47
Furosemide	Furosemide	173	48
Trazodone Hcl	Trazodone Hcl	168	44
Omeprazole	Omeprazole	155	43
Zolpidem Tartrate	Zolpidem Tartrate	151	40
Meloxicam	Meloxicam	147	44
Fluticasone Propionate	Fluticasone Propionate	144	45
Pioglitazone Hcl	Pioglitazone Hcl	128	33
Metoprolol Tartrate	Metoprolol Tartrate	127	34
Clopidogrel	Clopidogrel Bisulfate	113	34
Allopurinol	Allopurinol	109	28
Famotidine	Famotidine	107	28
Metformin Hcl Er	Metformin Hcl	106	27
Montelukast Sodium	Montelukast Sodium	106	25
Dexamethasone	Dexamethasone	102	85
Escitalopram Oxalate	Escitalopram Oxalate	95	20
Hydrochlorothiazide	Hydrochlorothiazide	92	27
Pravastatin Sodium	Pravastatin Sodium	88	23
Alprazolam	Alprazolam	84	15
Valsartan	Valsartan	80	16
Prednisone	Prednisone	77	52
Citalopram Hbr	Citalopram Hydrobromide	76	19
Lorazepam	Lorazepam	76	suppressed
Baclofen	Baclofen	74	28
Finasteride	Finasteride	74	19
Donepezil Hcl	Donepezil Hcl	70	14
Glipizide Er	Glipizide	68	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	67	21
Warfarin Sodium	Warfarin Sodium	62	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	61	15
Synthroid	Levothyroxine Sodium	61	16
Olmesartan Medoxomil	Olmesartan Medoxomil	60	13
Spironolactone	Spironolactone	60	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	59	23
Esomeprazole Magnesium	Esomeprazole Magnesium	58	16
Carvedilol	Carvedilol	57	18
Triamcinolone Acetonide	Triamcinolone Acetonide	56	39
Quetiapine Fumarate	Quetiapine Fumarate	55	18
Fluconazole	Fluconazole	54	27
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	52	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	51	suppressed
Duloxetine Hcl	Duloxetine Hcl	50	11
Albuterol Sulfate Hfa	Albuterol Sulfate	48	19
Venlafaxine Hcl Er	Venlafaxine Hcl	44	11
Chlorthalidone	Chlorthalidone	43	11
Jardiance	Empagliflozin	43	suppressed
Xarelto	Rivaroxaban	41	suppressed
Ozempic	Semaglutide	40	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	38	suppressed
Tizanidine Hcl	Tizanidine Hcl	37	11
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	35	suppressed
Torsemide	Torsemide	35	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	34	suppressed
Celecoxib	Celecoxib	34	suppressed
Cefuroxime	Cefuroxime Axetil	30	29
Bupropion Xl	Bupropion Hcl	28	suppressed
Mupirocin	Mupirocin	28	15
Azithromycin	Azithromycin	27	27
Ezetimibe	Ezetimibe	25	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	24	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Nystatin	Nystatin	24	17
Pregabalin	Pregabalin	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	21
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	22
Glimepiride	Glimepiride	23	suppressed
Clonazepam	Clonazepam	22	suppressed
Entresto	Sacubitril/Valsartan	22	suppressed
Methenamine Hippurate	Methenamine Hippurate	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	11
Estradiol	Estradiol	21	suppressed
Nadolol	Nadolol	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	20	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	11
Ramipril	Ramipril	19	suppressed
Repatha Sureclick	Evolocumab	19	suppressed
Colestipol Hcl	Colestipol Hcl	18	suppressed
Amiodarone Hcl	Amiodarone Hcl	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Glipizide	Glipizide	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Nitroglycerin	Nitroglycerin	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Diazepam	Diazepam	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	11
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Levemir Flexpen	Insulin Detemir	16	suppressed
Olanzapine	Olanzapine	16	suppressed
Primidone	Primidone	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Digoxin	Digoxin	13	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Dexmethylphenidate Hcl Er	Dexmethylphenidate Hcl	11	suppressed
Lamotrigine Odt	Lamotrigine	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Novolog Mix 70-30	Insulin Aspart Prot/Insuln Asp	11	suppressed
Testosterone	Testosterone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error